Seminar- Dr. Jonathan Lynch
Jonathan Lynch
MBIM Seminar Series
Starts
Apr 01, 2025 - 12:30 pmAdd to Calendar 2025-04-01 19:30:00 2025-04-01 19:30:00 Seminar- Dr. Jonathan Lynch

Seminar: Lipids, Cholesterol, and Neurotransmitters: Mediators of Host-Microbiota Interactions

 

Abstract: The mammalian intestinal tract is colonized by a complex microbial community called the gut microbiota. This community both responds to and affects host physiology in diverse ways. We are interested in how gut bacteria interact with host lipids, cholesterol, and neurotransmitters. We are exploring bacterial chemical processes that reshape systemic host lipid and cholesterol metabolism, and are investigating how lipid-mediating gut bacteria respond to dietary lipids. In addition, we are interested in how gut bacteria interact with neurotransmitters and drugs that modulate neurotransmitter activity, such as antidepressants. Together, we aim to define biochemical links between the gut microbiota and host physiology that will allow us to understand and shape metabolic and neurobiological health.

LSC 3 (Life Sciences Institute - 2350 Health Sciences Mall) MBIM itsupport@microbiology.ubc.ca America/Vancouver public
Ends
Apr 01, 2025 - 1:30 pm
Location
LSC 3 (Life Sciences Institute - 2350 Health Sciences Mall)
Hosted by
Dr. Carolina Tropini
Presenter title
Assistant Professor Department of Biological Chemistry, Johns Hopkins School of Medicine
Presenter name
Dr. Jonathan Lynch

Seminar: Lipids, Cholesterol, and Neurotransmitters: Mediators of Host-Microbiota Interactions

 

Abstract: The mammalian intestinal tract is colonized by a complex microbial community called the gut microbiota. This community both responds to and affects host physiology in diverse ways. We are interested in how gut bacteria interact with host lipids, cholesterol, and neurotransmitters. We are exploring bacterial chemical processes that reshape systemic host lipid and cholesterol metabolism, and are investigating how lipid-mediating gut bacteria respond to dietary lipids. In addition, we are interested in how gut bacteria interact with neurotransmitters and drugs that modulate neurotransmitter activity, such as antidepressants. Together, we aim to define biochemical links between the gut microbiota and host physiology that will allow us to understand and shape metabolic and neurobiological health.